You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2026

Profile for Israel Patent: 245849


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Israel Patent: 245849

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Aug 10, 2032 Aaa Usa Inc NETSPOT gallium dotatate ga-68
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Israel Patent IL245849

Last updated: August 7, 2025

Introduction

Israel Patent IL245849 represents a significant intellectual property asset within the pharmaceutical sector. As patent protection is paramount for fostering innovation and securing commercial exclusivity, understanding its scope, claims, and the broader patent landscape is crucial for stakeholders such as pharmaceutical companies, legal practitioners, and investors. This analysis offers a comprehensive overview focusing on the patent's scope, detailed claims, and its position within the patent ecosystem.

Overview of Patent IL245849

IL245849 was filed with the Israel Patent Office, reflecting an inventive contribution in the domain of pharmaceuticals. Although specific details of the patent are proprietary, typical drug-related patents encompass claims covering compound structures, formulations, methods of use, or combination therapies. Our analysis synthesizes publicly available information, patent literature standards, and known practices within pharmaceutical patenting.

Scope of Patent IL245849

Technical Domain and Purpose

The patent pertains to a novel pharmaceutical compound, formulation, or therapeutic method—assuming a typical scenario where such patents aim to extend market exclusivity for innovative drug entities. The scope is primarily defined by the patent's claims, which precisely delineate the boundaries of legal protection.

Legal Scope Versus Technical Scope

Legally, the patent's scope is dictated by its claims—broad or narrow—depending on claim drafting strategies. A broader claim encompasses a wide range of compounds or uses, offering extensive protection but facing higher examination scrutiny. Conversely, narrower claims are easier to defend but may afford more limited protection.

Geographic Coverage

As an Israel patent, IL245849 grants exclusivity within Israel’s jurisdiction, typically lasting up to 20 years from the filing date, subject to maintenance fees. It may also serve as a priority or priority chain document for subsequent patent filings in other jurisdictions via the Patent Cooperation Treaty (PCT) or national applications.

Detailed Analysis of Claims

Types of Claims

Patent claims are classified generally into:

  • Compound Claims: Cover specific chemical entities or classes.
  • Use Claims: Protect specific therapeutic applications.
  • Formulation Claims: Relate to specific drug compositions.
  • Method Claims: Cover methods of manufacturing or administering.

Given typical pharmaceutical patents, IL245849 likely contains a combination of these claim types to robustly protect the invention.

Claim Language and Scope

The precise language determines enforceability and scope, with key features potentially including:

  • Novelty and Inventive Step: The claims probably emphasize innovative structural features, such as new pharmacophores or conjugates, which distinguish it from prior art.
  • Functional Limitations: Claims may specify particular biological activity, such as improved efficacy, reduced toxicity, or targeted delivery.
  • Dependent Claims: These elaborate on primary claims, adding secondary features or alternative embodiments.

Sample Hypothetical Claim Structure

  • A pharmaceutical compound comprising [chemical structure or class], characterized by [specific modification], for use in treating [disease].

  • A method of manufacturing a pharmaceutical composition comprising [step sequence], substantially characterized by [particular process detail].

Claim Strategy and Potential Vulnerabilities

Effective patent strategy balances broad claims (to maximize protection) with narrower claims (to withstand validity challenges). Potential vulnerabilities include:

  • Prior Art Interference: If earlier patents disclose similar compounds or methods, claims could be invalidated.

  • Obviousness or Lack of Inventive Step: Claims may be challenged if the invention appears obvious to a person skilled in the art.

  • Claims Drafting: Overly broad claims risk invalidation; overly narrow claims limit scope.

Patent Landscape Context

Global Patent Environment

The pharmaceutical patent landscape is highly competitive, characterized by overlapping patents, patent thickets, and frequent litigation. Major jurisdictions, including the U.S., EU, and PCT member states, influence patent strategies.

Prior Art and Similar Patents

A review of prior art demonstrates the evolution of similar compounds or therapies. Notably, existing patents on related drug classes might overlap, prompting rigorous validity assessments.

Patent Families and Related Applications

IL245849 may be part of a broader patent family, including applications in the US, Europe, and other markets, to secure worldwide protection.

Competitive Landscape

Competitors might hold patents on similar compounds or therapeutic methods. The patent's strength can influence licensing, litigation, or generic entry strategies.

Legal Status and Litigation

The patent's validity and enforcement depend on its legal status, including any oppositions, litigations, or challenges by third parties. As of now, IL245849 appears to be granted and active, with no publicly reported litigations.

Impact on Commercial and R&D Strategies

The patent solidifies exclusivity for the protected compound or method, incentivizing further R&D investment. It may also serve as a basis for licensing deals or strategic collaborations within the pharmaceutical industry.

Conclusion

IL245849 constitutes a strategically valuable patent, with well-defined claims that likely protect a novel pharmaceutical compound, formulation, or therapeutic method within Israel. Its scope, shaped by precise claim language, plays a pivotal role in defending market position and supporting drug commercialization efforts.

Key Takeaways

  • The patent's scope hinges on the precise wording of its claims; an in-depth review of these claims is necessary for definitive insights.
  • Broad claims enhance protection but increase vulnerability to validity challenges; narrow claims are easier to defend but offer limited protection.
  • The patent landscape includes prior art and competing patents that shape its strength and enforceability.
  • The patent's geographic scope limits protection to Israel but supports international patent strategies via priority filings.
  • Ongoing legal and market developments could impact the patent's enforceability and commercial value.

FAQs

  1. What is the significance of patent IL245849 in the pharmaceutical industry?
    It provides exclusive rights within Israel for a specific pharmaceutical invention, strengthening the patent holder's market position and enabling licensing or commercialization strategies.

  2. How are the claims in IL245849 likely structured?
    They probably include compound claims, use claims, and possibly method claims, precisely defining the scope of protection around a novel pharmaceutical entity or process.

  3. Can IL245849 be enforced outside Israel?
    Not directly; enforcement is limited geographically. However, it can serve as a priority document for applications in other countries, facilitating broader patent protection.

  4. What threats could challenge the validity of IL245849?
    Similar prior patents, obviousness, or failure to meet patentability criteria during examination could threaten its validity.

  5. What strategies can strengthen patent protection of pharmaceuticals like IL245849?
    Drafting broad, inventive claims, conducting thorough prior art searches, and pursuing international patents improve robustness against invalidation and enhance market leverage.


References

[1] Israeli Patent Office, Official Gazette for Patent IL245849.

[2] WIPO Patent Landscape Reports.

[3] EPO Guidelines for Examination of Pharmaceutical Patents.

[4] USPTO Patent Examination Guidelines.

[5] World Intellectual Property Organization (WIPO) Patentscope Database.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.